VCP and PSMF1: Antagonistic regulators of proteasome activity

Clemen CS, Marko M, Strucksberg KH, Behrens J, Wittig I, Gaertner L, Winter L, Chevessier F, Matthias J, Türk M, Tangavelou K, Schütz J, Arhzaouy K, Klopffleisch K, Hanisch FG, Rottbauer W, Blümcke I, Just S, Eichinger L, Hofmann A, Schröder R (2015)


Publication Type: Journal article

Publication year: 2015

Journal

Book Volume: 463

Pages Range: 1210-7

Journal Issue: 4

DOI: 10.1016/j.bbrc.2015.06.086

Abstract

Protein turnover and quality control by the proteasome is of paramount importance for cell homeostasis. Dysfunction of the proteasome is associated with aging processes and human diseases such as neurodegeneration, cardiomyopathy, and cancer. The regulation, i.e. activation and inhibition of this fundamentally important protein degradation system, is still widely unexplored. We demonstrate here that the evolutionarily highly conserved type II triple-A ATPase VCP and the proteasome inhibitor PSMF1/PI31 interact directly, and antagonistically regulate proteasomal activity. Our data provide novel insights into the regulation of proteasomal activity.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Clemen, C.S., Marko, M., Strucksberg, K.-H., Behrens, J., Wittig, I., Gaertner, L.,... Schröder, R. (2015). VCP and PSMF1: Antagonistic regulators of proteasome activity. Biochemical and Biophysical Research Communications, 463(4), 1210-7. https://doi.org/10.1016/j.bbrc.2015.06.086

MLA:

Clemen, Christoph S., et al. "VCP and PSMF1: Antagonistic regulators of proteasome activity." Biochemical and Biophysical Research Communications 463.4 (2015): 1210-7.

BibTeX: Download